Health Care & Life Sciences » Pharmaceuticals | Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals Inc. | Income Statement

Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
1,550.00
9,897.60
18,446.00
13,982.20
Cost of Goods Sold (COGS) incl. D&A
1.40
1.40
-
-
-
15,216.10
Gross Income
1.40
1.40
-
-
-
1,233.90
SG&A Expense
4,283.20
11,302.00
8,448.10
17,633.70
11,348.10
19,956.50
EBIT
4,284.60
11,303.40
6,899.50
7,738.50
7,092.80
21,190.40
Unusual Expense
182.10
6.40
-
-
-
50
Non Operating Income/Expense
-
12.70
110.20
63.90
18.40
48.30
Interest Expense
553.00
160.30
28.20
11.90
3.70
-
Pretax Income
4,655.50
11,482.80
7,037.90
7,814.30
7,131.10
21,144
Income Tax
-
-
-
-
550.50
51.30
Consolidated Net Income
4,655.50
11,482.80
7,037.90
7,814.30
6,580.60
21,195.30
Net Income
4,655.50
11,482.80
7,037.90
7,814.30
6,580.60
21,195.30
Net Income After Extraordinaries
4,655.50
11,482.80
7,037.90
7,814.30
6,580.60
21,195.30
Net Income Available to Common
4,655.50
11,482.80
7,037.90
7,814.30
6,580.60
21,195.30
EPS (Basic)
3.25
6.57
1.75
4.09
2.94
7.10
Basic Shares Outstanding
1,432.40
1,747.90
4,032.70
1,910.50
2,014.50
2,985.30
EPS (Diluted)
3.25
6.57
1.75
4.09
2.94
7.10
Diluted Shares Outstanding
1,432.40
1,747.90
4,032.70
1,910.50
2,235.90
2,985.30
EBITDA
4,283.20
11,302.00
6,898.10
7,736.10
7,097.90
21,187.90
Non-Operating Interest Income
-
-
-
-
23.70
144.70

About Opiant Pharmaceuticals

View Profile
Address
201 Santa Monica Boulevard
Santa Monica California 90401
United States
Employees -
Website http://www.opiant.com
Updated 07/08/2019
Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.